Garden Stage Limited Ordinary Shares (GSIW)
USD 0.39
(-9.12%)
USD 0.39
(-9.12%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 180 Thousand | 415.79 Thousand | 296.28 Thousand | 6 Million |
| Cost of Revenue | 3.35 Million | 35.71 Thousand | 112.25 Thousand | 6.15 Million |
| Gross Profit | -3.17 Million | 380.08 Thousand | 184.02 Thousand | -151.81 Thousand |
| Operating Expenses | 5.98 Million | 1.11 Million | 535.72 Thousand | 233.79 Thousand |
| Selling, General and Administrative Expenses | 2.61 Million | 1.15 Million | 530.6 Thousand | 294.33 Thousand |
| Research and Development Expenses | - | - | - | - |
| Other Expenses | - | 2826.00 | 3342.00 | 11.62 Thousand |
| Cost and Expenses | 5.98 Million | 442.28 Thousand | 361.81 Thousand | 6.39 Million |
| Operating Income | -4.57 Million | -26.5 Thousand | -65.53 Thousand | -385.18 Thousand |
| Interest Expense | - | - | - | - |
| Income Tax Expense | 13.35 Thousand | -66.85 | 101.74 | -66.00 |
| Earnings before Tax | -4.57 Million | -26.49 Thousand | -65.52 Thousand | -329.6 Thousand |
| Net Income | -4.58 Million | -26.42 Thousand | -65.63 Thousand | -329.54 Thousand |
| Earnings Per Share Basic | -0.04 | -0.00 | -0.00 | -0.02 |
| Earnings Per Share Diluted | -0.04 | -0.00 | -0.00 | -0.02 |
| Weighted Average Shares Outstanding | 13.61 Million | 15.25 Million | 15.25 Million | 15 Million |
| Weighted Average Shares Outstanding (Diluted) | 13.61 Million | 15.25 Million | 15.25 Million | 15 Million |
| Gross Margin | -17.65 | 0.91 | 0.62 | -0.03 |
| EBIT Margin | -25.21 | -0.04 | -0.22 | -0.06 |
| Profit Margin | -25.50 | -0.06 | -0.22 | -0.05 |
| EBITDA | -4.53 Million | -16.4 Thousand | -64.13 Thousand | -380.99 Thousand |
| Earnings Before Tax Margin | -25.42 | -0.06 | -0.22 | -0.06 |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 328.92 Thousand | 180 Thousand | 328.92 Thousand | 95.84 Thousand | 375.31 Thousand | 1.03 Million |
| Cost of Revenue | 11.47 Thousand | 19.42 Thousand | - | 7950.00 | - | - |
| Gross Profit | 317.44 Thousand | 160.58 Thousand | 328.92 Thousand | 87.89 Thousand | 375.31 Thousand | 1.03 Million |
| Operating Expenses | 2.24 Million | 2.62 Million | 2.24 Million | 745.31 Thousand | 745.31 Thousand | 862.06 Thousand |
| Selling, General and Administrative Expenses | 1.38 Million | - | 1.38 Million | 5073.95 | 541.42 Thousand | 701.76 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -5.83 | 5259.00 | - | -0.99 | - | - |
| Cost and Expenses | 2.24 Million | 764.85 Thousand | 2.24 Million | -89.42 Thousand | 745.31 Thousand | 862.06 Thousand |
| Operating Income | -1.91 Million | -584.84 Thousand | -1.91 Million | -95.97 Thousand | -370 Thousand | 177.53 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 853.00 | 1707.33 | 853.00 | -0.01 | 5827.00 | 176.00 |
| Earnings before Tax | -1.91 Million | -584.84 Thousand | -1.91 Million | -0.01 | -370 Thousand | 177.53 Thousand |
| Net Income | -1.91 Million | -586.55 Thousand | -1.91 Million | 15.25 Million | -375.83 Thousand | 177.7 Thousand |
| Earnings Per Share Basic | -0.13 | - | -0.13 | 15.25 Million | -0.03 | 0.02 |
| Earnings Per Share Diluted | -0.13 | - | -0.13 | -0.06 | -0.03 | 0.02 |
| Weighted Average Shares Outstanding | 14.6 Million | 15.62 Million | 14.6 Million | 12.61 Million | 12.61 Million | 11.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 14.6 Million | 15.62 Million | 14.6 Million | 12.61 Million | 12.61 Million | 11.47 Million |
| Gross Margin | 0.97 | 0.89 | 1.00 | 0.92 | 1.00 | 1.00 |
| EBIT Margin | 0.00 | - | 0.00 | 0.02 | - | 0.00 |
| Profit Margin | -5.83 | -3.26 | -5.83 | 159.11 | -1.00 | 0.17 |
| EBITDA | 1.00 | - | 1.00 | 1488.08 | - | 352.00 |
| Earnings Before Tax Margin | -5.83 | -3.25 | -5.83 | -1.00 | -0.99 | 0.17 |
FHYDF
1201
AGM-PE
ICNM
DMET
4189